Target intelligence / Profile preview

Ferroportin-1 (FPN (also SLC40A1))

Target
FPN (also SLC40A1)
Molecular classification
Transporter, Major facilitator superfamily (MFS) transporter
01

Overview

Ferroportin-1 (FPN or SLC40A1) is the only known iron exporter in mammals, encoded by the SLC40A1 gene[1][2][3][5][7][8]. It is a transmembrane protein primarily responsible for transporting iron from enterocytes, hepatocytes, and reticuloendothelial macrophages into the bloodstream, thus regulating systemic iron balance. FPN function is tightly regulated by the hormone hepcidin: when plasma iron is high, hepcidin binds FPN, triggering its degradation and thereby reducing iron export; when iron is low, decreased hepcidin leads to increased FPN at cell surfaces and thus greater iron release. Mutations in SLC40A1 cause hereditary hemochromatosis type 4 (ferroportin disease), characterized by pathological iron overload and end-organ damage[3][4]. Ferroportin also plays a role in preventing iron-mediated oxidative damage and in controlling ferroptosis, a form of cell death linked to various diseases including cancer[2]. FPN is part of the major facilitator superfamily and is expressed in tissues inherently involved in iron absorption and storage, such as intestinal enterocytes, macrophages, hepatocytes, and placental syncytiotrophoblasts[1][8].

Other names
Solute carrier family 40 member 1SLC40A1FPN1IREG1SLC11A3MSTP079MTP1HFE4Iron-regulated transporter 1FerroportinIron-regulated gene 1SLC40 iron transporter
02

Mechanism of action

Hepcidin binds to ferroportin, causing its internalization and degradation, thus reducing iron efflux. Modulation of the hepcidin–ferroportin interaction to restore or inhibit iron export.

03

Biological functions

Iron export from cellsRegulation of systemic iron homeostasisCellular iron releaseControl of dietary iron absorption
04

Disease associations

Hereditary hemochromatosis (ferroportin disease, type 4 hemochromatosis)Iron overload disordersAnemia of chronic diseaseCardiovascular diseaseCancer (via association with ferroptosis)
05

Safety considerations

Dysregulation can lead to iron overload syndromes (liver cirrhosis, diabetes, heart disease)Inhibition may cause iron-restricted anemiaTargeting affects essential systemic iron handling; high risk of secondary effects on any iron-dependent tissue
06

Interacting drugs

Minihepcidins (hepcidin analogs/modulators; in investigational or preclinical development)

1 more in the full profile.

07

Biomarkers

Serum ferritin (indirect)Serum transferrin saturation (indirect)Genetic testing for SLC40A1 mutations in suspected hemochromatosis

Beyond the preview

Go deeper on Ferroportin-1 (FPN (also SLC40A1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferroportin-1 (FPN (also SLC40A1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call